| Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ... Science 370 (6520), eabd4250, 2020 | 587 | 2020 |
| Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics C Muus, MD Luecken, G Eraslan, L Sikkema, A Waghray, G Heimberg, ... Nature medicine 27 (3), 546-559, 2021 | 298 | 2021 |
| Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions MR Filbin, A Mehta, AM Schneider, KR Kays, JR Guess, M Gentili, ... Cell Reports Medicine 2 (5), 100287, 2021 | 192 | 2021 |
| Profound Treg perturbations correlate with COVID-19 severity S Galván-Peña, J Leon, K Chowdhary, DA Michelson, B Vijaykumar, ... Proceedings of the National Academy of Sciences 118 (37), e2111315118, 2021 | 134 | 2021 |
| Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... Cell 184 (15), 3962-3980. e17, 2021 | 109 | 2021 |
| SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes Y Li, AM Schneider, A Mehta, M Sade-Feldman, KR Kays, M Gentili, ... The Journal of Clinical Investigation 131 (13), 2021 | 109 | 2021 |
| Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2 JM Francis, D Leistritz-Edwards, A Dunn, C Tarr, J Lehman, C Dempsey, ... Science immunology 7 (67), eabk3070, 2021 | 74 | 2021 |
| Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 P Kaplonek, C Wang, Y Bartsch, S Fischinger, MJ Gorman, K Bowman, ... Science immunology 6 (64), eabj2901, 2021 | 62 | 2021 |
| Alveolar, endothelial, and organ injury marker dynamics in severe COVID-19 DE Leisman, A Mehta, BT Thompson, NC Charland, ALK Gonye, ... American Journal of Respiratory and Critical Care Medicine 205 (5), 507-519, 2022 | 61 | 2022 |
| Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19 AA Schmaier, GMP Hurtado, ZJ Manickas-Hill, KD Sack, SM Chen, ... JCI insight 6 (20), 2021 | 42 | 2021 |
| Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients TJ LaSalle, ALK Gonye, SS Freeman, P Kaplonek, I Gushterova, KR Kays, ... Cell Reports Medicine 3 (10), 100779, 2022 | 38 | 2022 |
| Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection NJ Silverstein, Y Wang, Z Manickas-Hill, C Carbone, A Dauphin, ... elife 11, e74681, 2022 | 37 | 2022 |
| SARS-CoV-2 epitope–specific CD4+ memory T cell responses across COVID-19 disease severity and antibody durability RW Nelson, Y Chen, OL Venezia, RM Majerus, DS Shin, ... Science immunology 7 (73), eabl9464, 2022 | 30 | 2022 |
| Plasma P‐selectin is an early marker of thromboembolism in COVID‐19 BG Fenyves, A Mehta, MGH COVID, KR Kays, C Beakes, J Margolin, ... American journal of hematology 96 (12), E468, 2021 | 30 | 2021 |
| Type I, II, and III interferon signatures correspond to coronavirus disease 2019 severity MH Kim, S Salloum, JY Wang, LP Wong, J Regan, K Lefteri, ... The Journal of infectious diseases 224 (5), 777-782, 2021 | 29 | 2021 |
| A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma J Alladina, NP Smith, T Kooistra, K Slowikowski, IJ Kernin, J Deguine, ... Science immunology 8 (83), eabq6352, 2023 | 24 | 2023 |
| Altered interactions between circulating and tissue-resident CD8 T cells with the colonic mucosa define colitis associated with immune checkpoint inhibitors MF Thomas, K Slowikowski, K Manakongtreecheep, P Sen, J Tantivit, ... BioRxiv, 2021.09. 17.460868, 2021 | 14 | 2021 |
| Single-cell profiling of human heart and blood in immune checkpoint inhibitor-associated myocarditis. SM Blum, DA Zlotoff, N Smith, S Ramesh, I Kernin, P Sen, L Zubiri, ... Journal of Clinical Oncology 40 (16_suppl), 2507-2507, 2022 | 2 | 2022 |
| 1242 Altered interactions between circulating and tissue-resident CD8 T cells with the colonic mucosa define checkpoint inhibitor colitis K Slowikowski, M Thomas, K Manakongtreecheep, P Sen, J Tantivit, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| 441 Checkpoint inhibitor-associated inflammatory arthritis is comprised of multiple clinical endotypes characterized by distinct transcriptional programs G Reynolds, M Nasrallah, N Smith, M Thomas, L Zubiri, A Tirard, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
